US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Healius Limited (HLS) 銘柄情報

Healius Limited (HLS)

0.3775

-0.0025

(-0.66%)

終了 7月4日 3:00PM

Healius Limited (HLS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.3775

( -0.66% )

買値

0.375

売値

0.38

出来高

715,221

0.3725 日の範囲 0.385

0.30 52 週間の範囲 1.07

時価総額

前日終値

0.38

始値

0.375

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 5,183,426

発行済株式数

726,132,843

配当利回り

PER

-0.52

1 株当たり利益 (EPS)

-0.23

歳入

1.37B

純利益

-168.8M

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ P... Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.healius.com.au

本社

Sydney, Australia

設立

1994

Healius Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker HLS. The last closing price for Healius was AUD0.38. Over the last year, Healius shares have traded in a share price range of AUD 0.30 to AUD 1.07.

Healius currently has 726,132,843 shares in issue. The market capitalisation of Healius is AUD274.12 million. Healius has a price to earnings ratio (PE ratio) of -0.52.

Former Leighton Executive Found Guilty of Criminal Charges

By Rhiannon Hoyle SYDNEY--A former finance executive at Leighton Holdings, now known as Cimic Group Ltd. (CIM.AU), was found guilty of conduct...

HealthSouth Posts 4Q Profit, Sees 2009 Earnings Above View

HealthSouth Corp. (HLS) swung to a fourth-quarter profit on sharply lower costs and a $121.3 million gain from settling with UBS AG's (UBS...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0275	7.85714285714	0.35	0.405	0.35	4820873	0.38227468	DE
4	0.0575	17.96875	0.32	0.415	0.3	5605180	0.36719227	DE
12	-0.1475	-28.0952380952	0.525	0.575	0.3	5077547	0.40477955	DE
26	-0.5275	-58.2872928177	0.905	1.0475	0.3	4114698	0.53729245	DE
52	-0.3725	-49.6666666667	0.75	1.07	0.3	3791370	0.67376951	DE
156	-2.7925	-88.0914826498	3.17	3.2	0.3	2966716	1.10567427	DE
260	-4.1825	-91.7214912281	4.56	5.54	0.3	2740863	2.0945991	DE

HLS - Frequently Asked Questions (FAQ)

What is the current Healius Limited share price?

The current share price of Healius Limited is AUD 0.3775

How many Healius Limited shares are in issue?

Healius Limited has 726,132,843 shares in issue

What is the market cap of Healius Limited?

The market capitalisation of Healius Limited is AUD 274.12M

What is the 1 year trading range for Healius Limited share price?

Healius Limited has traded in the range of AUD 0.30 to AUD 1.07 during the past year

What is the PE ratio of Healius Limited?

The price to earnings ratio of Healius Limited is -0.52

What is the cash to sales ratio of Healius Limited?

The cash to sales ratio of Healius Limited is 0.21

What is the registered address of Healius Limited?

The registered address for Healius Limited is 161 Castlereagh Street, Sydney, New South Wales, 2000

What is the Healius Limited website address?

The website address for Healius Limited is www.healius.com.au

Which industry sector does Healius Limited operate in?

Healius Limited operates in the Medical Diagnostics & Screening sector

monkeybusiness

monkeybusiness 3分前

Mask the codes and do third-party testing on the tech!

Lone Clone

Lone Clone 7分前

Oreterra Geological Staff Mobilize to Trek South Copper-Gold Prospect, Golden Triangle, BC, to Prepare for Maiden Drill Program

https://www.newsfilecorp.com/release/303897/Oreterra-Geological-Staff-Mobilize-to-Trek-South-CopperGold-Prospect-Golden-Triangle-BC-to-Prepare-for-Maiden-Dr

Doc logic

Doc logic 8分前

Idunno,

BP’s last hope is their influence on US patent office decisions. Once the combo comes through they are cooked; ). Best wishes.

Hey_Its_That_Guy

Hey_Its_That_Guy 9分前

We at least you have an uplisted by now

BigMoneyChalupa

BigMoneyChalupa 9分前

I still question why the convertible note holders are not aggressively dumping their millions of $$$'s in convertible bonds into the bid. Legitimate question and not being sarcastic at all. I mean it is crazy to me how they have all these convertible loans and an available bid to dump into, and yet

Vexari

Vexari 11分前

How so
Nope. That is inappropriate.. Not looking good for dr. Falsi hey boys! Watch him rat out a bit on bourlap dog. What's behind the curtain

manibiotech

manibiotech 11分前

Not sure how do you reach at 6-9 months conclusion . You do realize that 9 months is 270 days which would be more than long enough for new application submission without any clock off periods . I strongly disagree with your conclusion unless you can give any precedence/any other example or the facts

indepth05

indepth05 11分前

We need to stop the conspiracy framing and deal with the actual, observable mechanics and historical facts, because that is what reality is built on in markets like this.
Lehman’s reported ~$600B balance sheet was never a pool of liquid, realisable capital. It was a gross accounting structure

SkyLimit2022

SkyLimit2022 12分前

The reference to the https://clinicaltrials.gov/study/NCT04201873 combo with Hiltonol & Keytruda was particularly noteworthy along with the specific
https://www.nature.com/articles/s41467-024-48073-y Nature Comms citation. NCT04201873 has an estimated primary completion date of Aug 1

kfa670

kfa670 12分前

Maybe a stupid question but...

With this data now in hand, would it make sense to go after an FDA approval in conjunction with MHRA?

Lone Clone

Lone Clone 12分前

Blast Resources Announces Exploration Results at Its Flagship Wales Lake Project in the Athabasca Basin Region, Saskatchewan

https://www.newsfilecorp.com/release/303832/Blast-Resources-Announces-Exploration-Results-at-Its-Flagship-Wales-Lake-Project-in-the-Athabasca-Basin-Region-Saska

Forensics888

Forensics888 13分前

Could be, but when one is in a situation like this and Trump has already acknowledged the atrocity of this in his letter regarding socialism - it would be best for them to come out as heroes and end this, instead of victims of a court ruling.

This is Trump's mantra - America first, Am

boston745

boston745 16分前

Here again media is publishing articles with misinformation in its headlines. Before there were several articles indicating Autopilot used used meanwhile the body of the article would say self driving. Now The Guardian is claiming Tesla said that Mr. Butler disengaged FSD when he supposedly applied

boston745

boston745 17分前

Here again media is publishing articles with misinformation in its headlines. Before there were several articles indicating Autopilot used used meanwhile the body of the article would say self driving. Now The Guardian is claiming Tesla said that Mr. Butler disengaged FSD when he supposedly applied

reg2015

reg2015 18分前

Does any one knoe what NWBO closed at today in London? Thank you. Peace Reg2015

attilathehunt

attilathehunt 18分前

You said…"and in my view the MHRA's review of it will take at least 6 to 9 months. So if NWBO submitted it around March, we're realistically looking at another 4 to 7 months of waiting from here before a decision."

What if they submitted the data in December? Then only one month….

Zadie420

Zadie420 18分前

The question is did NWBO prided this finding to MHRA for further consideration, If yes, then when.....

flipper44

flipper44 19分前

I think it’s for a NICE evidence submission. My guess is MHRA already reviewed it, and perhaps they even helped, regardless, NWBO needs to be transparent about the process.

beartrap12

beartrap12 19分前

On multiple looks, it appears this chart on page 6 is the original survival figures used in JAMA. If so, the PSM analysis doubles that delta (distance between the treated group and the PSM matches). It's hard to tell without Dr. Bosch's words explaining what you're looking at in these slides. But Bo

desert rat1

desert rat1 20分前

Yes iam still holding firm I been waiting 6years for a company to stike a profit

Us old timers are on the verge of a breakout Be patience I now its hard to do. I have held for 6 years

nunaka

nunaka 21分前

You're so childish... just give it a rest, already.

Dodger1

Dodger1 21分前

The one year chart looks great!!! I asked ole fabled AI a question! if a token was 30 cents and is now 7 cents what percentage drop in price is that and how many percent would it take to get back to 30 cents from 7 cents

Google AI:
AI Overview A drop from 30 c

InvestInBiel

InvestInBiel 22分前

One just has to read the recent Chairman update...

"Our cost control efforts included relocating our offices and reducing staff to better align with current operational needs. As a result, the Company reported a small profit for calendar year 2025. We also initiated several programs i

HGiLS

Potential buyers look at the current manipulated market value as the baseline price versus the real market value

Wild Brush Energy (EM)

Pepper Residential Secur...

Progress 2019 1

NYLI Candriam Internatio...

Denki Kogyo (PK)

FIP Endurance Debt

Pearl Gull Iron

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。